Cryoablation study for paroxysmal atrial fibrillation after approval
Part of Heart & circulation clinical trials.
This study looks at outcomes after a specific heart procedure called pulmonary vein isolation done with a cryoablation catheter. It is for adults with symptomatic “paroxysmal” atrial fibrillation who are planning this exact procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with symptomatic paroxysmal atrial fibrillation (AF that comes and goes)
- You are at least 18 years old (or the local minimum age allowed)
- You are planning pulmonary vein isolation (PVI) using the Arctic Front cryoablation catheter
- You can and will follow the study rules and sign an informed consent form (or your local authorization process)
- You should not be taking class I or class III anti-arrhythmia medicines (especially sotalol) with the goal of preventing AF relapse
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat paroxysmal atrial fibrillation (AF) using pulsed field energy. The goal is to block abnormal electrical signals from the pulmonary veins and superior vena cava, which may help prevent AF episodes from coming back.
This trial tests a new balloon cryoablation system to treat paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes). It aims to see if this device can safely and effectively restore a normal heart rhythm.
This study tests a new approach to a common procedure for atrial fibrillation (AFib) called pulmonary vein isolation. It uses a single-shot cryoablation technique to treat people with paroxysmal or persistent AFib.
This trial tests a new treatment that uses two types of energy (pulsed field and radiofrequency) to fix the heart's electrical signals in people with paroxysmal atrial fibrillation (AFib that comes and goes). It aims to be more effective and safer than standard ablation alone.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new catheter that uses pulsed field energy to isolate the veins in your heart that trigger atrial fibrillation. The goal is to see how long the effects last, and you would need to have a repeat procedure about 2–3 months after the first one.
Hear when a new Paroxysmal Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.